Eton Pharmaceuticals (ETON) Change in Account Payables (2018 - 2025)

Eton Pharmaceuticals has reported Change in Account Payables for 8 years, with the latest figure at -$3.3 million in Q4 2025.

• Quarterly Change in Account Payables fell 321.59% year-over-year to -$3.3 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $6.8 million (up 193.7% YoY) and the FY2025 annual result came in at $6.8 million, up 193.7% from the prior year.
• Change in Account Payables retreated to -$3.3 million in Q4 2025 per ETON's latest filing, from $2.1 million in the prior quarter.
• Over five years, Change in Account Payables peaked at $7.3 million in Q2 2025 and troughed at -$3.3 million in Q4 2025.
• A 5-year average of $430050.0 and a median of $11500.0 in 2022 frame the typical range for Change in Account Payables.
• The sharpest annual moves came in 2021 and 2025: Change in Account Payables slumped 1033.09% in 2021, then jumped 5688.46% in 2025.
• Over 5 years, Change in Account Payables stood at -$1.3 million in 2021, then jumped by 156.11% to $712000.0 in 2022, then slumped by 85.25% to $105000.0 in 2023, then soared by 1311.43% to $1.5 million in 2024, then sank by 321.59% to -$3.3 million in 2025.
• According to Business Quant data, Change in Account Payables over the past three periods registered -$3.3 million, $2.1 million, and $7.3 million for Q4 2025, Q3 2025, and Q2 2025 respectively.